about
Increased expression of epidermal growth factor receptor (EGF-R) in patients with different forms of lung fibrosis.Metabolism considerations for kinase inhibitors in cancer treatmentRe-administration of gefitinib following diffuse interstitial lung disease in a patient with advanced lung adenocarcinoma: A case report and review of the literatureGefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report.Icotinib combined with rapamycin in a renal transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer: A case report.Gefitinib-induced interstitial pneumonia: A case report and review of the literature.Pulmonary toxicities from targeted therapies: a review.Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.Erlotinib achieved partial response in a non-small cell lung cancer patient with gefitinib-induced interstitial lung disease.Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease.Outcome in advanced non-small cell lung cancer patients with successful rechallenge after recovery from epidermal growth factor receptor tyrosine kinase inhibitor-induced interstitial lung disease.Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma.[Gefitinib-induced acute lung injury: a case report and review of the literature].Re-administration of Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer Who Recovered from Chemotherapy-induced Interstitial Lung Disease
P2860
Q30540860-9DD9C7DA-7E02-4543-9325-4FDD705D1D3EQ34134390-1AC646E9-012D-4ABB-9ED9-7352DD3393C6Q35742303-7844592D-9D3D-407D-A2D6-560D9E8E77B0Q36918853-60D62213-E0B7-4994-B6F5-9AECEF93AF33Q37388707-0699EBB0-47F7-4840-8368-002C0B6F5ECCQ37652133-8D376881-66A7-44B7-81D3-D39D88D9B714Q37955066-24BDA6FE-B319-4BB3-BDB9-D9EC72E871E1Q38930166-AD444A6A-D5CE-45E4-A773-B859DB2BD1FCQ39256314-E0DB49C0-7E0B-4622-B9D2-12CDAF45ECFDQ47743515-12179026-34E6-4800-86EF-2E9BD3C16037Q47959927-053685C2-8141-4685-98E5-DF3CD9B97817Q50348815-37FD66BF-B3B6-4120-ACA1-3AFE96E6BCB1Q55443106-6BC44568-B2A0-4096-B0B3-2CD62B54A56EQ56529425-39729138-3AED-44C5-9350-DA85EC6D9BF5
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Recurrent gefitinib-induced interstitial lung disease.
@en
Recurrent gefitinib-induced interstitial lung disease.
@nl
type
label
Recurrent gefitinib-induced interstitial lung disease.
@en
Recurrent gefitinib-induced interstitial lung disease.
@nl
prefLabel
Recurrent gefitinib-induced interstitial lung disease.
@en
Recurrent gefitinib-induced interstitial lung disease.
@nl
P2093
P1433
P1476
Recurrent gefitinib-induced interstitial lung disease
@en
P2093
Jun Konishi
Koichi Yamazaki
Masaru Suzuki
P304
P356
10.2169/INTERNALMEDICINE.47.0737
P577
2008-03-17T00:00:00Z